JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jos L J,van der Velden

第一单位： Department of Pathology, University of Vermont, Burlington, VT, USA.

作者： Jos L J,van der Velden ^[1] ; Ying,Ye ^[2] ; James D,Nolin ^[1] ; Sidra M,Hoffman ^[1] ; David G,Chapman ^[1] ; Karolyn G,Lahue ^[1] ; Sarah,Abdalla ^[1] ; Peng,Chen ^[3] ; Yong,Liu ^[2] ; Brydon,Bennett ^[4] ; Nasreen,Khalil ^[5] ; Donna,Sutherland ^[3] ; William,Smith ^[3] ; Gerald,Horan ^[2] ; Mahmoud,Assaf ^[2] ; Zebulun,Horowitz ^[3] ; Rajesh,Chopra ^[2] ; Randall M,Stevens ^[3] ; Maria,Palmisano ^[2] ; Yvonne M W,Janssen-Heininger ^[1] ; Peter H,Schafer ^[6]

作者单位： Department of Pathology, University of Vermont, Burlington, VT, USA. ^[1] Department of Translational Development, Celgene Corporation, 86 Morris Avenue, Summit, NJ, 07901, USA. ^[2] Clinical Research and Development, Celgene Corporation, Warren, NJ, USA. ^[3] Department of Inflammation Research, Celgene Corporation, San Diego, CA, USA. ^[4] Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada. ^[5] Department of Translational Development, Celgene Corporation, 86 Morris Avenue, Summit, NJ, 07901, USA. pschafer@celgene.com. ^[6]

关键词 Biomarkers CC-930 Idiopathic pulmonary fibrosis JNK Matrix metalloproteinase 7 Surfactant protein D Tenascin-C

DOI 10.1186/s40169-016-0117-2

PMID 27590145

发布时间 2022-01-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览31

Clinical and translational medicine

2016年5卷1期

36页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers.

Clinical and translational medicine

相似文献

Clinical and translational medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers.

Clinical and translational medicine

相似文献

Clinical and translational medicine

相关期刊

检索历史清除